Monoclonal Mouse anti‑Human CDKN2D / p19 INK4d Antibody (clone DCS‑100, IHC, WB) LS‑C179602
Monoclonal Mouse anti‑Human CDKN2D / p19 INK4d Antibody (clone DCS‑100, IHC, WB) LS‑C179602
Antibody:
CDKN2D / p19 INK4d Mouse anti-Human Monoclonal (DCS-100) Antibody
Application:
IHC, IHC-P, WB, IP
Format:
Unconjugated, Unmodified
Overview
Antibody:
CDKN2D / p19 INK4d Mouse anti-Human Monoclonal (DCS-100) Antibody
Application:
IHC, IHC-P, WB, IP
Format:
Unconjugated, Unmodified
Specifications
Description
P19 INK4d antibody LS-C179602 is an unconjugated mouse monoclonal antibody to human p19 INK4d (CDKN2D). Validated for IHC, IP and WB.
Target
Human CDKN2D / p19 INK4d
Synonyms
CDKN2D | CDK inhibitor p19INK4d | INK4D | p19 | p19 INK4d | p19-INK4D
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG1
Monoclonal
Conjugations
Unconjugated
Purification
Protein A purified
Immunogen
Recombinant Human full length p19INK4d.
Specificity
Human CDKN2D / p19 INK4d
Applications
- IHC
- IHC - Paraffin (1 - 5 µg/ml)
- Western blot (1 µg/ml)
- Immunoprecipitation
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Usage
IHC: Heat treatment is necessary for paraffin-embedded sections;IP: 3 ug/200-300 ul of cell extract;
Presentation
PBS, pH 7.2, 50% Glycerol
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
Western blot, Immunoprecipitation, ELISA
Species:
Human
Applications:
IHC, Peptide Enzyme-Linked Immunosorbent Assay
Species:
Human, Mouse
Applications:
IHC, IHC - Paraffin, Western blot, Flow Cytometry
Source:
E. coli
Tag:
His-GST
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 11/27/2024